HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of microsatellite instability using Promega panel in dermatofibrosarcoma protuberans.

Abstract
Dermatofibrosarcoma protuberans (DFSP) is a rare neoplasm derived from fibroblasts. Although the frequency of microsatellite instability (MSI) in skin cancer is reported to be less than 5%, there is only one report of the status of MMR in DFSP. The only analytical report of microsatellite stability in which Promega panel is not used, showed that the frequency of MSI-high, MSI-low and microsatellite stable (MSS) cases was 13.9% (5/36), 16.7% (6/36) and 69.4% (25/36), respectively. Thus, the aim of this study was to evaluate the status of MMR in 36 patients with DFSP diagnosed at Kumamoto University. MSI analysis using the Promega panel showed that all cases were MSS, which indicated the absence of MSI in DFSP. This result indicates that the status of MMR may not be useful for the potential therapeutic application of pembrolizumab and the pathogenesis of DFSP may not involve MSI.
AuthorsSaki Maeda-Otsuka, Myangat Tselmeg Mijiddorj, Ikko Kajihara, Yuki Nishimura, Hisashi Kanemaru, Soichiro Sawamura, Katsunari Makino, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
JournalBioscience trends (Biosci Trends) Vol. 16 Issue 2 Pg. 176-177 (May 17 2022) ISSN: 1881-7823 [Electronic] Japan
PMID35185112 (Publication Type: Journal Article)
Chemical References
  • Fatty Acids, Omega-3
  • Promega
Topics
  • Dermatofibrosarcoma (genetics, pathology)
  • Fatty Acids, Omega-3
  • Humans
  • Microsatellite Instability
  • Skin Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: